Statins and the risk of pancreatic cancer: A systematic review and meta-analysis of 2,797,186 patients
Authors:
- Eryka KarbowskaEKEryka Karbowska
- Damian SwieczkowskiDSDamian Swieczkowski
- Aleksandra GaseckaAleksandra Gasecka
- Michal PrucMPMichal Pruc
- Kamil SafiejkoKSKamil Safiejko
- Jerzy R. LadnyJLJerzy R. Ladny
- Tomasz KopiecTKTomasz Kopiec
- Milosz J. JaguszewskiMJMilosz J. Jaguszewski
- Krzysztof J. FilipiakKFKrzysztof J. Filipiak
- Zubaid RafiqueZRZubaid Rafique
- Lukasz SzarpakLukasz Szarpak
Open Access
- 26 April 2024
- journal article
- review article
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 31 (2) , 243-250
Abstract
Background: Statin use in many studies is related to the improvement of a patients’ condition including reducing the risk of various malignancies. Herein, is a systematic review and meta-analysis to examine the evidence on the association between statin therapy and the risk of the occurrence of pancreatic cancer, mainly in terms of decreased risk of developing pancreatic cancer among patients using statin therapy in the long-term perspective. Methods: PubMed, Web of Science, Scopus and Cochrane Central Register of Controlled Trials (CENTRAL) were searched from database inception to December 1st, 2021. Random effect models were used to estimate summary odds ratios (OR) and the corresponding 95% confidence intervals (CI). Results: A total of 26 studies comprising 2,797,186 patients were included. Polled analysis showed that pancreatic cancer occurrence in statin vs. no-statin group varied and amounted to 0.4% vs. 0.6% (RR = 0.83; 95% CI: 0.72–0.96; I2 = 84%; p = 0.01). Conclusions: In summary, the present analysis shows that overall statins use is significantly associated with a reduction in risk of pancreatic cancer. However, these results were not confirmed for the randomized controlled trial subgroup. Further prospective studies are needed to confirm the current results. Background: Statin use in many studies is related to the improvement of a patients’ condition including reducing the risk of various malignancies. Herein, is a systematic review and meta-analysis to examine the evidence on the association between statin therapy and the risk of the occurrence of pancreatic cancer, mainly in terms of decreased risk of developing pancreatic cancer among patients using statin therapy in the long-term perspective. Methods: PubMed, Web of Science, Scopus and Cochrane Central Register of Controlled Trials (CENTRAL) were searched from database inception to December 1st, 2021. Random effect models were used to estimate summary odds ratios (OR) and the corresponding 95% confidence intervals (CI). Results: A total of 26 studies comprising 2,797,186 patients were included. Polled analysis showed that pancreatic cancer occurrence in statin vs. no-statin group varied and amounted to 0.4% vs. 0.6% (RR = 0.83; 95% CI: 0.72–0.96; I2 = 84%; p = 0.01). Conclusions: In summary, the present analysis shows that overall statins use is significantly associated with a reduction in risk of pancreatic cancer. However, these results were not confirmed for the randomized controlled trial subgroup. Further prospective studies are needed to confirm the current results.Keywords
This publication has 54 references indexed in Scilit:
- Common cancer risk and statins: a population-based case–control study in a Chinese populationExpert Opinion on Drug Safety, 2012
- Aspirin, Nonsteroidal Anti-inflammatory Drugs, Acetaminophen, and Pancreatic Cancer Risk: a Clinic-Based Case–Control StudyCancer Prevention Research, 2011
- Exposure to statins and risk of common cancers: a series of nested case-control studiesBMC Cancer, 2011
- Statins and Risk of CancerJACC, 2011
- Statin Use and the Risk of Pancreatic CancerPancreas, 2011
- Incidence of cancer and statin usage—Record linkage studyInternational Journal of Cancer, 2009
- Statins and Cancer RiskThe American Journal of Medicine, 2008
- Statin Use and the Risk of 10 CancersEpidemiology, 2007
- The Risk of Cancer in Users of StatinsJournal of Clinical Oncology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003